{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:24:30Z","timestamp":1792628670625,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001236","name":"Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001236","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jhep.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T01:46:18Z","timestamp":1500515178000},"page":"1324-1331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":399,"title":["Acetaminophen (APAP) hepatotoxicity\u2014Isn\u2019t it time for APAP to go away?"],"prefix":"10.1016","volume":"67","author":[{"given":"William M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.07.005_b0005","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pds.1191","article-title":"Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States","volume":"15","author":"Nourjah","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jhep.2017.07.005_b0010","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.07.005_b0020","unstructured":"http:\/\/www.pharmacytimes.com\/publications\/issue\/2013\/July2013\/Top-200-Drugs-of-2012, accessed May 10, 2016."},{"key":"10.1016\/j.jhep.2017.07.005_b0025","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.20437","article-title":"Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes","volume":"40","author":"Kon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.07.005_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/0192623308329282","article-title":"Sensitivity of liver injury in heterozygous Sod2 knockout mice treated with troglitazone or acetaminophen","volume":"37","author":"Fujimoto","year":"2009","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jhep.2017.07.005_b0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.3.5722.557","article-title":"Acute paracetamol poisoning","volume":"3","author":"Proudfoot","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.jhep.2017.07.005_b0040","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1981.00340030112020","article-title":"Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment","volume":"141","author":"Rumack","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/cpt1974164676","article-title":"Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy","volume":"16","author":"Mitchell","year":"1974","journal-title":"Clin Pharmacol Therap"},{"key":"10.1016\/j.jhep.2017.07.005_b0050","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/21-539_Acetadote.cfm, accessed on June 26, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0055","unstructured":"Federal Register 1982: Labeling for Salicylate Compounds http:\/\/cdn.loc.gov\/service\/ll\/fedreg\/fr047\/fr047249\/fr047249.pdf#page=214, accessed on June 15, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0060","unstructured":"http:\/\/cdn.loc.gov\/service\/ll\/fedreg\/fr047\/fr047249\/fr047249.pdf#page=214 FDA monograph suggesting a warning to be put on aspirin in regard to use in children under 16 for influenza symptoms\u20141982."},{"key":"10.1016\/j.jhep.2017.07.005_b0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.1980.03310030027020","article-title":"Potentiation of acetaminophen hepatotoxicity by alcohol","volume":"244","author":"McClain","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2017.07.005_b0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-104-3-399","article-title":"Acetaminophen toxicity in alcoholics","volume":"104","author":"Seeff","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007611-199009000-00017","article-title":"Acetaminophen hepatotoxicity in the alcoholic","volume":"83","author":"Wootton","year":"1990","journal-title":"Southern Med J"},{"key":"10.1016\/j.jhep.2017.07.005_b0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840220312","article-title":"Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure","volume":"22","author":"Zimmerman","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.07.005_b0085","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","article-title":"Medical progress: acute liver failure","volume":"329","author":"Lee","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0090","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","article-title":"Acetaminophen toxicity in an urban county hospital","volume":"337","author":"Schi\u00f8dt","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cgh.2014.07.011","article-title":"Risk factors and outcomes of acute kidney injury in patients with acute liver failure","volume":"13","author":"Tujios","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2017.07.005_b0100","unstructured":"James LP. Acetaminophen: Pathology and clinical presentation of hepatotoxicity, in Kaplowitz N, Deleve LD. Drug-Induced Liver Disease (Third Edition) Amsterdam 2013, pp. 331\u2013341."},{"key":"10.1016\/j.jhep.2017.07.005_b0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.25656","article-title":"Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: Early discrimination between survival and death","volume":"56","author":"Remien","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.07.005_b0110","first-page":"163","article-title":"Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria","volume":"6","author":"Shakil","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2017.07.005_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.500050102","article-title":"Etiology and outcome for 295 patients with acute liver failure in the United States","volume":"5","author":"Schi\u00f8dt","year":"1999","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.jhep.2017.07.005_b0120","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure (ALF) from 1998\u20132013: An observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2017.07.005_b0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.3.5722.557","article-title":"Acute paracetamol poisoning","volume":"3","author":"Proudfoot","year":"1970","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2017.07.005_b0130","unstructured":"Lancet Editorial (unsigned), December 13 1975, p. 1189."},{"key":"10.1016\/j.jhep.2017.07.005_b0135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1192\/bjp.161.6.816","article-title":"Deliberate self-poisoning and self-injury in adolescents. A study of characteristics and trends in Oxford, 1976\u201389","volume":"161","author":"Hawton","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jhep.2017.07.005_b0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/bjp.168.1.43","article-title":"Paracetamol self-poisoning. characteristics, prevention and harm reduction","volume":"168","author":"Hawton","year":"1996","journal-title":"Br J Psych"},{"key":"10.1016\/j.jhep.2017.07.005_b0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/bmj.1.6003.212","article-title":"Why do people use paracetamol for suicide?","volume":"i","author":"Gazzard","year":"1976","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2017.07.005_b0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00127-007-0199-7","article-title":"Self-harm in England: a tale of three cities","volume":"42","author":"Hawton","year":"2007","journal-title":"Soc Psychiatr Epidemiol"},{"key":"10.1016\/j.jhep.2017.07.005_b0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/bmj.f403","article-title":"Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses","volume":"346","author":"Hawton","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2017.07.005_b0160","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/15563650903093192","article-title":"Limiting paracetamol pack size: has it worked in the UK?","volume":"47","author":"Bateman","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jhep.2017.07.005_b0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2710.2007.00842.x","article-title":"Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre","volume":"32","author":"Morgan","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jhep.2017.07.005_b0170","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/bmj.38253.572581.7C","article-title":"UK legislation on analgesic packs: before and after study of long term effect on poisonings","volume":"329","author":"Hawton","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2017.07.005_b0175","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.07.005_b0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2125.2010.03819.x","article-title":"Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity","volume":"71","author":"Craig","year":"2010","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.jhep.2017.07.005_b0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2125.2011.04067.x","article-title":"Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity","volume":"73","author":"Craig","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2017.07.005_b0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/mcp.2002.121857","article-title":"The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdose","volume":"71","author":"Schi\u00f8dt","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2017.07.005_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/clpt.2010.164","article-title":"Point-counterpoint: The case for limiting acetaminophen-related deaths: Smaller doses and unbundling the opioid-acetaminophen compounds","volume":"88","author":"Lee","year":"2010","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.jhep.2017.07.005_b0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/liv.12632","article-title":"Two-year outcomes in initial survivors with acute liver failure: Results from a prospective, multicenter study","volume":"35","author":"Fontana","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2017.07.005_b0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/lt.24347","article-title":"Determinants of outcome among patients with acute liver failure listed for liver transplantation in the US","volume":"22","author":"Reddy","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2017.07.005_b0210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/lt.21681","article-title":"The utilisation of liver transplantation in the management of acute liver failure: Comparison between acetaminophen and non-acetaminophen etiologies","volume":"15","author":"Simpson","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2017.07.005_b0215","unstructured":"https:\/\/wayback.archive-it.org\/7993\/20161022165242\/http:\/\/www.fda.gov\/Drugs\/ScienceResearch\/ResearchAreas\/ucm091365.htm, accessed June 14, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0220","unstructured":"www.fda.gov\/ohrms\/dockets\/ac\/02\/slides\/3882s1_01_ganley.pdf, accessed June 14, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0225","unstructured":"https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/DrugSafetyandRiskManagementAdvisoryCommittee\/UCM174699.pdf dated January 13, 2011, accessed June 14, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0230","unstructured":"https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm239821.htm, accessed June 19, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10787-010-0036-6","article-title":"FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?","volume":"18","author":"Graham","year":"2010","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.jhep.2017.07.005_b0240","unstructured":"https:\/\/www.propublica.org\/article\/tylenol-mcneil-fda-use-only-as-directed, accessed June 19, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0245","unstructured":"https:\/\/www.propublica.org\/article\/johnson-johnson-emerges-victorious-in-lawsuit-on-tylenols-risks, accessed June 19, 2017."},{"key":"10.1016\/j.jhep.2017.07.005_b0250","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 annual report of the american association of poison control centers\u2019 national poison data system","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jhep.2017.07.005_b0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/11595890-000000000-00000","article-title":"Trends in hepatic injury associated with unintentional overdose of paracetamol (acetaminophen) with or without opioid","volume":"35","author":"Bond","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2017.07.005_b0260","first-page":"1445","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR"},{"key":"10.1016\/j.jhep.2017.07.005_b0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0041-008X(86)90329-7","article-title":"Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection","volume":"83","author":"Miller","year":"1986","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2017.07.005_b0270","first-page":"7","article-title":"Cimetidine protects against acetaminophen hepatoxicity","volume":"23","author":"Jackson","year":"1981","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.jhep.2017.07.005_b0275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00045391-200205000-00007","article-title":"Next generation of everyday analgesics","volume":"9","author":"Brune","year":"2002","journal-title":"Am J Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817321487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817321487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:16:28Z","timestamp":1536290188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817321487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0168827817321487"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.07.005","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetaminophen (APAP) hepatotoxicity\u2014Isn\u2019t it time for APAP to go away?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}